Translation Inhibition through eIF4A1 Targeting in Multiple Myeloma Is a Promising Therapeutic Strategy

被引：0

作者：

Dutrieux, Laure ^{[1
]}

Loughran, Elle ^{[2
,3
]}

Choquet, Armelle ^{[4
]}

Herault, Helene ^{[4
]}

Guillemin, Antoine ^{[1
]}

Robert, Nicolas ^{[5
]}

Requirand, Guilhem ^{[5
]}

Cartron, Guillaume ^{[6
,7
,8
]}

Vincent, Laure ^{[9
]}

Herbaux, Charles ^{[10
,11
,12
]}

Rivals, Eric ^{[2
]}

David, Alexandre ^{[4
]}

Moreaux, Jerome ^{[1
,5
,12
,13
,14
,15
,16
]}

机构：

[1] Inst Genet Humaine, Montpellier, France

[2] LIRMM, Montpellier, France

[3] Trin Coll, Dublin, Ireland

[4] Inst Genet Fonctionnelle, Montpellier, France

[5] Montpellier Univ Hosp Ctr, Dept Biol Hematol, Lab Monitoring Innovat Therapies, Montpellier, France

[6] Montpellier Univ Hosp Ctr, Dept Biol Hematol, Montpellier, France

[7] Montpellier Univ Hosp Ctr, Clin Hematol Dept, Montpellier, France

[8] Univ Montpellier, IGMM UMR 5535 CNRS UM, Montpellier, France

[9] Montpellier Univ Hosp Ctr, Dept Clin Hematol, Montpellier, France

[10] Univ Montpellier, Fac Med, Montpellier, France

[11] Montpellier Univ Hosp, Dept Clin Hematol, Montpellier, France

[12] Univ Montpellier, CNRS UMR, Inst Human Genet, Montpellier, France

[13] Univ Med, Fac Med, Montpellier, France

[14] Inst Univ France, Paris, France

[15] Montpellier Univ Hosp, Dept Biol Hematol, Lab Monitoring Innovat Therapies, Montpellier, France

[16] Univ Montpellier, Montpellier, France

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-184749

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[41] TLR4 Targeting as a Promising Therapeutic Strategy for Alzheimer Disease Treatment
Zhou, Yongji
Chen, Yanxing
Xu, Congcong
Zhang, Hao
Lin, Caixiu
FRONTIERS IN NEUROSCIENCE, 2020, 14
[42] Duchenne cardiomyopathy: targeting ROS and NOX4 as a promising therapeutic strategy
Sampaolesi, Maurilio
Janssens, Stefan
Duelen, Robin
EXPERT OPINION ON THERAPEUTIC TARGETS, 2023, 27 (02) : 91 - 95
[43] Inhibition of WHSC1 As a Promising Therapeutic Strategy in Childhood ALL
Khoury, Haytham
Raynal, Noel
St-Onge, Pascal
Caron, Maxime
Beaudry, Annie
Sinnett, Daniel
BLOOD, 2017, 130
[44] Therapeutic targeting of eukaryotic translation initiation factor 4 gamma 1 (EIF4G1) in enzalutamide resistant (ENZR) prostate cancer
Jaiswal, Praveen K.
Koul, Sweaty
Sankaralingam, Saikolappan
Koul, Hari K.
CANCER RESEARCH, 2022, 82 (12)
[45] Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy
Chung, Clement
PHARMACOTHERAPY, 2017, 37 (01): : 129 - 143
[46] Noncytotoxic Inhibition of Viral Infection through eIF4F-Independent Suppression of Translation by 4EGi-1
McMahon, Robert
Zaborowska, Izabela
Walsh, Derek
JOURNAL OF VIROLOGY, 2011, 85 (02) : 853 - 864
[47] Multiple myeloma proteostasis can be targeted via translation initiation factor eIF4E
Zismanov, Victoria
Attar-Schneider, Oshrat
Lishner, Michael
Aizenfeld, Rachel Heffez
Matalon, Shelly Tartakover
Drucker, Liat
INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (02) : 860 - 870
[48] EIF4A1/2 INHIBITION DOWN-MODULATES THE OXIDATIVE STRESS RESPONSE AND PREVENTS LUNG METASTASIS IN OSTEOSARCOMA
Lizardo, Michael
Hughes, Christopher
Huang, Yue
Shyp, Taras
Delaidelli, Alberto
Zhang, Hai-Feng
Shaool, Sol
Sorensen, Poul
PEDIATRIC BLOOD & CANCER, 2023, 70 : S55 - S55
[49] Targeting the translation initiation complex component eIF4G1 in melanoma
Feng, Yongmei
Radaeva, Mariia
Kim, Hyungsoo
Deshpande, Anagha
Deshpande, Ani
Jovanovic, Predrag
Murad, Rabi
Topisirovic, Ivan
Olson, Steven
Cherkasov, Artem
Ronai, Ze'ev
CANCER RESEARCH, 2024, 84 (06)
[50] The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma
Crawford, Lisa J.
Campbell, David C.
Morgan, Jonathan J.
Lawson, Michelle A.
Down, Jennifer M.
Chauhan, Dharminder
McAvera, Roisin M.
Morris, Treen C.
Hamilton, Claudia
Krishnan, Aswini
Rajalingam, Krishnaraj
Chantry, Andrew D.
Irvine, Alexandra E.
ONCOGENE, 2020, 39 (27) : 5001 - 5014

← 1 2 3 4 5 →